NCT02088515View on ClinicalTrials.gov

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

PHASE4CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

February 28, 2017

Conditions
Squamous Cell Carcinoma
Interventions
DRUG

Nedaplatin

DRUG

Cisplatin

DRUG

Docetaxel

Trial Locations (4)

200000

Shanghai Chest hospital, Shanghai

Unknown

Hunan Xiangya Hospital, Changsha

Nanjing Military General Hospital, Nanjing

Xijing Hospital, Xian

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY